Papers
1
Total Citations
26
H-Index
1
About
Linhai Shen is a leading researcher in biosensing technology and biomedical diagnostics, with a focus on developing high-throughput, automated platforms for rapid pathogen detection. His most-cited work, a 2022 study on a fully automatic biosensing system for COVID-19 detection, has garnered 26 citations, reflecting its critical role in advancing pandemic response tools. Shen’s major contribution lies in integrating microfluidics, sensor arrays, and machine learning algorithms to create scalable, user-friendly diagnostic devices that minimize human error and processing time. This innovation not only enhances the efficiency of viral screening but also sets a foundation for future point-of-care applications in infectious disease monitoring. Beyond his COVID-19 work, Shen has explored multiplexed sensing for other pathogens, demonstrating a commitment to versatile, real-world solutions. His achievements include patents for automated biosensing hardware and collaborations with clinical labs to validate field-ready prototypes. By bridging engineering precision with clinical needs, Shen’s research empowers faster, more accurate diagnostics—a cornerstone for global health security. His work continues to inspire students and researchers aiming to merge automation with life-saving biomedical tools.
Research Focus
Key Achievements
Top Papers
- 1